Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 158.77B | 159.23B | 135.01B | 124.08B | 83.42B | 98.40B |
Gross Profit | 35.30B | 36.31B | 22.92B | 15.01B | -4.13B | -5.09B |
EBITDA | 34.91B | 33.23B | 23.89B | 15.17B | -3.97B | -14.49B |
Net Income | 30.96B | 26.25B | 19.95B | 11.19B | -8.42B | -18.78B |
Balance Sheet | ||||||
Total Assets | 199.21B | 209.04B | 174.79B | 124.90B | 123.72B | 111.56B |
Cash, Cash Equivalents and Short-Term Investments | 71.06B | 90.14B | 55.39B | 29.46B | 25.28B | 13.51B |
Total Debt | 11.83B | 18.24B | 13.32B | 11.94B | 15.23B | 17.59B |
Total Liabilities | 97.62B | 103.89B | 94.89B | 74.94B | 86.55B | 71.20B |
Stockholders Equity | 101.22B | 105.14B | 79.68B | 49.96B | 37.17B | 40.36B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 32.42B | 25.47B | 6.92B | 13.56B | -30.56B |
Operating Cash Flow | 0.00 | 37.73B | 27.41B | 9.00B | 15.10B | -26.64B |
Investing Cash Flow | 0.00 | -5.26B | -1.92B | -1.26B | -715.00M | -4.07B |
Financing Cash Flow | 0.00 | 2.29B | 571.00M | -3.38B | -2.50B | -124.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | €209.13B | 8.01 | 28.11% | 0.99% | 17.94% | 31.45% | |
78 Outperform | ¥9.52B | 7.93 | 2.67% | 7.08% | 165.25% | ||
74 Outperform | ¥275.33B | 7.08 | 24.36% | 0.73% | 4.38% | 55.40% | |
70 Neutral | ¥169.78B | 10.60 | 4.42% | 3.10% | 5.63% | -31.54% | |
68 Neutral | ¥9.49B | 9.34 | 0.71% | -3.74% | -55.02% |